Docosahexaenoic Acids: Clinical Trials

344 trials of Docosahexaenoic Acids, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

216 completed, 59 unknown, 19 terminated, 15 recruiting. 159 Not applicable, 74 Phase 2, 69 Phase 3, 32 Phase 4, 21 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable159Completed 97, Unknown 22, Active not recruiting 10, Recruiting 8, Not yet recruiting 7, Terminated 6, Withdrawn 5, Enrolling by invitation 4
Phase 274Completed 47, Unknown 16, Terminated 3, Active not recruiting 2, Recruiting 2, Enrolling by invitation 1, Not yet recruiting 1, Suspended 1, Withdrawn 1
Phase 369Completed 51, Unknown 10, Terminated 5, Recruiting 3
Phase 432Completed 17, Unknown 9, Recruiting 2, Terminated 2, Active not recruiting 1, Withdrawn 1
Phase 121Completed 14, Unknown 3, Terminated 2, Enrolling by invitation 1, Withdrawn 1
Early Phase 112Completed 6, Unknown 3, Terminated 2, Recruiting 1

Follow Docosahexaenoic Acids: new trials by email Literature Review of Docosahexaenoic Acids trials Research Report on Docosahexaenoic Acids

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Fish Oil Supplementation on the Voice of Female Professional Voice Users (PVU)
Omega-3 Polyunsaturated Fatty Acids - Mitigation of Acute Voice Changes Follwing Rigorous Voice Use
Not applicableNot yet recruitingBaylor University682026-10-012026-09-02
Supplementation Absorption Comparison
Aquacelle® Omega 3, Comparator Omega 3, Plexosome® Vitamin D3 - Healthy Volunteer
Phase 4RecruitingRDC Clinical Pty Ltd1602026-08-312026-09-10
Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial
Omega-3 (EPA+DHA), Placebo - Tuberculosis, Inflammation Biomarkers
Phase 2RecruitingNorth-West University, South Africa402026-08-192026-09-09
Impact of an Optimized Omega-3 Formulation on Inflammation and Endothelial Dysfunction in Pulmonary Arterial Hypertension
OMega 3 - PAH
Not applicableNot yet recruitingUniversity Hospital, Strasbourg, France222026-07-012026-07-13
Dietary Supplements and Middle Aged Women (Collagen & Omega)
Collagen peptides and omega-3, Placebo control - Cognition, Inflammation Biomarkers
Not applicableRecruitingLoughborough University342026-05-012026-08-03
Impact of an Omega-3 Enriched Oral Nutritional Supplement on Improving Surgical Outcomes in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery
ONS enriched with Omega-3, Standard ONS - Peritoneal Carcinosis, Peritoneal Metastases
Not applicableNot yet recruitingCatholic University of the Sacred Heart282026-04-012026-03-17
Long-Term Omega-3 and Omega-3 Index >8%: Effects on Physiological Recovery
Oil Supplementation - Focus on Omega 3 Index on Recovery
Not applicableNot yet recruitingSt. Mary's University, Twickenham462026-02-282026-02-27
Effects of DHA in Patients With Multiple Sclerosis
Docosahexaenoic Acid (DHA) Dietary Supplement, Sunflower Oil - Multiple Sclerosis, Performance Enhancement
Not applicableEnrolling by invitationFrancisco Javier Martínez Noguera1002026-01-012026-01-16
Immunonutrition for Surgical Prehabilitation of Patients With Upper GI Cancer
Oral nutritional supplements with immunonutrition (enriched with arginine, nucleotides, vitamin D and omega-3-fatty acid), Standart of care - Upper GI Cancer
Not applicableEnrolling by invitationFundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal1102026-01-012026-10-20
Omega-Cold Supplementation With Free Fatty Acids for the Prevention of Respiratory Infections in Adults.
Omega-3 oil with 2% Free Fatty Acids, Vegatable oil - Respiratory Infections
Not applicableRecruitingLandspitali University Hospital4002025-12-192026-08-28
Regenerative Root Canal Treatment of Immature Teeth Using Omega-3 Fatty Acids
Omega -3 fatty acids, Calcium Hydroxide (Ca(OH)2) - Immature Permanent Teeth With Open Apex, Pulp Necrosis
Not applicableActive not recruitingMansoura University202025-10-012026-01-28
Pilot Assessment of the Safety of a Combination of Curcumin, Omega-3, and Vitamin D Supplements in ACPA+ Individuals
curcumin, omega-3, and vitamin D (COD) - Healthy Participants
Not applicableNot yet recruitingUniversity of Manitoba502025-10-012025-08-01
Omega-3 Fatty Acids in Muscle Function and Health
Omega-3, Placebo comparator - Healthy
Not applicableNot yet recruitingEuropean University Cyprus322025-09-012025-08-21
Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma
Toripalimab, Omega-3, radiotherapy - Nasopharyngeal Carcinoma (NPC)
Phase 2Not yet recruitingAffiliated Hospital of Guangdong Medical University302025-08-222025-08-22
Differential Thrombogenesis by EPA and DHA Mediated by HDL
EPA, DHA - Lipid Metabolism Disorders, Hypertriglyceridemia
Early Phase 1RecruitingThe Miriam Hospital802025-07-102025-10-01
ICOPE INTENSE-K Pilot Study
ICOPE intense intervention, Ketone Ester (KE) supplementation, Placebo - Ageing
Not applicableRecruitingUniversity Hospital, Toulouse402025-07-092025-07-23
Exploring Sustainable Alternatives to Marine Oils With Echium and Ahiflower Oils
Echium oil, Ahiflower oil, EPA capsules - Cardiovascular (CV) Risk, Atheroscleroses
Not applicableActive not recruitingUniversity of Sao Paulo152025-05-262025-12-17
Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation.
Omega-3 Lipid Emulsion - Graft-Versus-Host Disease(GVHD)
Phase 1 / Phase 2Enrolling by invitationFujian Medical University302025-05-162025-11-18
Effect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy
omega-3 polyunsaturated fatty acids (PUFA n-3), Olive oil (placebo) - Pregnant HIV Positive Women
Not applicableEnrolling by invitationInstituto Nacional de Perinatologia Isidro Espinosa de los Reyes922025-05-142025-09-11
Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome.
Omega 3 fatty acids, Omega -3 fatty acids - PCOS (Polycystic Ovary Syndrome)
Not applicableEnrolling by invitationBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh682025-04-222025-07-24

Showing 20 of 344. Sign in to see all of them.

Conditions studied

Inflammation (29)  ·  Obesity (19)  ·  Cardiovascular Diseases (13)  ·  Breast Neoplasms (11)  ·  Depression (11)  ·  Attention Deficit Disorder with Hyperactivity (9)  ·  Diabetes Mellitus, Type 2 (9)  ·  Non-alcoholic Fatty Liver Disease (8)  ·  Depressive Disorder, Major (7)  ·  Insulin Resistance (7)  ·  Motor Activity (7)  ·  Premature Birth (7)  ·  Sarcopenia (7)  ·  Cognitive Dysfunction (6)  ·  Coronary Artery Disease (6)

Sponsors

Brigham and Women's Hospital (7)  ·  Coordinación de Investigación en Salud, Mexico (7)  ·  Tehran University of Medical Sciences (6)  ·  University of Manitoba (6)  ·  American Regent, Inc. (5)  ·  Mayo Clinic (5)  ·  University of Cincinnati (5)  ·  Ain Shams University (3)  ·  Cairo University (3)  ·  China Medical University Hospital (3)  ·  Loughborough University (3)  ·  Massachusetts General Hospital (3)  ·  Retina Foundation of the Southwest (3)  ·  Texas Tech University (3)  ·  The University of New South Wales (3)

Countries

United States (121)  ·  Canada (27)  ·  Brazil (16)  ·  Egypt (15)  ·  Spain (14)  ·  China (10)  ·  Iran (10)  ·  Italy (10)  ·  Mexico (10)  ·  United Kingdom (10)  ·  Norway (9)  ·  France (8)  ·  Taiwan (8)  ·  Chile (5)  ·  Germany (5)

Top investigators

Mariela Bernabe-Garcia, PhD (3)  ·  Mark A Falone, MD (3)  ·  Ahmed F Mahmoud Hussein, MS.c (2)  ·  Daisuke Nishi, M.D., Ph.D. (2)  ·  Gordon B Parker, Dsc MD PhD (2)  ·  Kathleen Gustafson, PhD (2)  ·  Kuan-Pin Su, M.D., Ph.D. (2)  ·  Lynsey S Wilson, MSc (2)  ·  Marcelo J Amar, M.D. (2)  ·  Mauro Santamaria, Professor (2)  ·  Melanie Plourde, PhD (2)  ·  Pei-Chen Chang, MD, PhD (2)  ·  Robert McNamara, PhD (2)  ·  Sarah Keim, PhD (2)

Results publications

PMID 34817851, PMID 37058600, PMID 31004139, PMID 37702300, PMID 10816186, PMID 12112073, PMID 15290734, PMID 15364708, PMID 15364709, PMID 15643744, PMID 16324089, PMID 16530201, PMID 17684201, PMID 18156400, PMID 18234997, PMID 18327998, PMID 18421079, PMID 18541599, PMID 19056592, PMID 19064745, PMID 19249410, PMID 19328438, PMID 19331677, PMID 19843899, PMID 20130094, PMID 20213818, PMID 20393114, PMID 20498621, PMID 20520307, PMID 20572767, PMID 20597641, PMID 20631232, PMID 20683766, PMID 21045096, PMID 21233083, PMID 21303552, PMID 21502576, PMID 21665007, PMID 21720194, PMID 21742090, PMID 21775114, PMID 21999398, PMID 22000478, PMID 22136711, PMID 22640930, PMID 22686415, PMID 22686416, PMID 22751375, PMID 22821626, PMID 22879423

NIH funding

2009 (2), 2019 (2), R01HD047315 (2), 1RC2AG036535 (1), 2008 (1), 2016 (1), 5UL1TR000135 (1), KL2TR000136 (1), N01CN00034 (1), N01CN35159 (1), P30CA016672 (1), P30CA069533 (1), P30ES009089 (1), R01AG029562 (1), R01AG054454 (1)